The move may affect multinational cos that have been trying to withdraw their high-end stents from India after the drug pricing watchdog ca...

The government is expected to hold discussions to decide on these requests only in February, a year after it first capped prices of these l...

The department of pharmaceuticals (DoP) said it had come across reports regarding shortage of coronary stents in the market and in hospital...

The move comes in the wake of various multinationals, including Abbott and Medtronic, seeking permission to withdraw some of their products...

As per the government, the NPPA was closely monitoring the situation and has alerted the state governments and state drugs controllers to m...

The National Pharmaceutical Pricing Authority (NPPA) met stent makers and importers today to discuss issues like pricing and availability o...

The regulator has been taking several steps to ensure stents are available under its prescribed price list as reports emerged that there we...

These show cause notices have been sent after preliminary investigations into these allegations, the regulator disclosed on its official ac...

We have not overcharged even a single patient for stent. We have complied fully and immediately with the NPPA order on stent pricing, a Max...

The department of pharmaceutical has also invoked special provisions under the DPCO to ensure compliance with the pricing order as well as ...

In case of non-compliance of NPPA's instructions, the regulator said it may be constrained to invoke provisions of legal prosecution under ...

Last week, the government had slashed prices of stents by up to 85 per cent by capping them at Rs 7,260 for bare metal ones and Rs 29,600 f...

Under the Section 3 (i) of DPCO, 2013, the govt can regulate distribution and direct any manufacturer to increase production and sell produ...

Following the NPPA decision, some companies have reportedly withdrawn high-priced stents, leading to an artificial shortage of the product.

A cardiologist who spoke to ET on condition of anonymity said some companies, especially importers, have asked hospitals not to use stents ...

There are reports of shortages of stents in hospitals after the government reduced their prices by up to 85 per cent by capping rates of ba...

There have been reports of “artificial” shortage of stents since National Pharmaceutical Pricing Authority (NPPA) capped prices of these li...